In a new book, Dr. Manish Arora and Dr. Paul Curtin of the Mount Sinai Institute for Exposomic Research suggest that a newly proposed component—the biodynamic interface—may better explain how humans interact with their environment
In an interview with Spectrum magazine, Dr. Manish Arora described what is next for the company’s hair based early autism diagnosis tool, StrandDx
New study suggests persistent exposure to air pollutants in residential communities can impact health outcomes for COVID-19 patients
StrandDx™- ASD Exposome Sequencing Diagnostic was developed based on technology developed by researchers in the Institute for Exposomic Research at Mount Sinai.
Researchers use a novel machine learning algorithm to discover that early exposure to a variety of toxic air pollutants can lead to poor asthma outcomes
Collaborative Climate Research Effort to Be Conducted in Partnership with Academic Institutions, Science Organizations, Community Leaders, and Industry Representatives. Dr. Perry Sheffield of the Institute for Exposomic Research will lead the Health and Safety Workgroup
Subject to regulatory approvals, the new company intends to launch its first product with StrandDx™- ASD a molecular biomarker for autism spectrum disorder that can be applied at birth, and can assist in early Autism Spectrum Disorder diagnosis.
Rescue and recovery workers who attended the World Trade Center site are beginning to develop chronic obstructive pulmonary disease (COPD), according to research presented at the European Respiratory Society International Congress by Mount Sinai researchers.
A new peer-reviewed study in Nature Communications shows how pre-existing neighborhood social factors like housing, work, income, insurance help explain the higher rates of infection for COVID19 in communities of color.
Researchers from the Mount Sinai Institute for Exposomic Research are first to find ultrafine particles from traffic pollution influences asthma risk in U.S. children